Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00546598 · ClinicalTrials.gov registry record · Phase 4
Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System
A Phase 4 study, sponsored by DePuy Orthopaedics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 106
- Enrollment target
NCT00546598 is a Phase 4 study that was terminated before completion, run by DePuy Orthopaedics. The registered enrollment target is 106 participants.
The verdict
NCT00546598, a Phase 4 study, was terminated before completion, sponsored by DePuy Orthopaedics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 106 participants
- Enrollment target
Study Summary
This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.
Interventions
- DEVICE Total hip replacement/arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-01-01 |
| Est. Completion | 2014-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00546598
The ClinicalTrials.gov registry entry for NCT00546598 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy Orthopaedics, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Total hip replacement/arthroplasty is the first listed.
NCT00546598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00546598 about?
NCT00546598 is a clinical study titled "Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System". This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.
What is the current status of trial NCT00546598?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 106 participants. The study started on 2006-01-01. Estimated completion is 2014-04-01.
What interventions are being tested in trial NCT00546598?
The interventions under investigation include: Total hip replacement/arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT00546598?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.